TLR agonist rHP-NAP as an Adjuvant of Dendritic Cell-Based Vaccine to Enhance Anti-Melanoma Response
Background: Melanoma is a common and malignant cutaneous tumor, which is responsible for a large proportion of skin cancer deaths. Dendritic cell (DC)-based vaccines have achieved positive results in the treatment of melanoma because of their ability to induce cytotoxic response to facilitate tumor...
Main Authors: | Meiling Hou, Xiaodong Wang, Jike Lu, Xun Guo, Cong Ding, Taotao Liang, Zhenyu Ji, Peng Xie, Xin Liu, Qiaozhen Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2020-03-01
|
Series: | Iranian Journal of Immunology |
Subjects: | |
Online Access: | https://iji.sums.ac.ir/article_46472_0702ab433bd224599f8c3fe5028e909c.pdf |
Similar Items
-
Pseudomonas savastanoi Two-Component System RhpRS Switches between Virulence and Metabolism by Tuning Phosphorylation State and Sensing Nutritional Conditions
by: Yingpeng Xie, et al.
Published: (2019-03-01) -
A Theoretical Framework to Determine RHP Zero Dynamics in Sequential Interacting Sub-Systems
by: Anca Maxim, et al.
Published: (2019-05-01) -
The experience of a Power Nap Center in the largest city of Brazil
by: Rogerio Santos-Silva, et al.
Published: (2016-07-01) -
Relationship between nap and hypertension in adults: An updated meta-analysis
by: Meng-Yang He, et al.
Published: (2020-08-01) -
Spotlight on daytime napping during early childhood
by: Horváth K, et al.
Published: (2018-03-01)